Literature DB >> 8985151

Purification of acid sphingomyelinase from human placenta: characterization and N-terminal sequence.

S Lansmann1, K Ferlinz, R Hurwitz, O Bartelsen, G Glombitza, K Sandhoff.   

Abstract

Human placental acid sphingomyelinase (ASM) was purified by sequential chromatography on Con A-Sepharose, octyl-Sepharose and Matrex gel red A. Final purification to apparent homogeneity was achieved by immunoaffinity chromatography employing polyclonal anti-ASM antibodies. The antibodies also allowed specific detection of ASM by Western blotting at various stages of purification. The ASM activity was enriched about 110,000-fold over that of the crude extract, yielding an enzyme preparation with a specific activity of about 1 mmol/h per mg protein in a detergent-containing assay system. Analysis of the final preparation by SDS-PAGE resulted in a single protein band with a molecular mass of approximately 75 kDa, which was reduced to approximately 60 kDa after complete deglycosylation. Microsequencing of the purified ASM revealed the N-terminal amino acid sequence of the mature placental enzyme.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8985151     DOI: 10.1016/s0014-5793(96)01331-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

Review 1.  Ceramide-rich platforms in transmembrane signaling.

Authors:  Branka Stancevic; Richard Kolesnick
Journal:  FEBS Lett       Date:  2010-02-20       Impact factor: 4.124

2.  A novel mechanism of lysosomal acid sphingomyelinase maturation: requirement for carboxyl-terminal proteolytic processing.

Authors:  Russell W Jenkins; Jolanta Idkowiak-Baldys; Fabio Simbari; Daniel Canals; Patrick Roddy; Clarke D Riner; Christopher J Clarke; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

Review 3.  Sphingolipids in the DNA damage response.

Authors:  Brittany Carroll; Jane Catalina Donaldson; Lina Obeid
Journal:  Adv Biol Regul       Date:  2014-11-18

Review 4.  Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.

Authors:  Melani Solomon; Silvia Muro
Journal:  Adv Drug Deliv Rev       Date:  2017-05-11       Impact factor: 15.470

5.  A high-throughput sphingomyelinase assay using natural substrate.

Authors:  Miao Xu; Ke Liu; Noel Southall; Juan J Marugan; Alan T Remaley; Wei Zheng
Journal:  Anal Bioanal Chem       Date:  2012-06-19       Impact factor: 4.142

Review 6.  The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.

Authors:  Eric L Smith; Edward H Schuchman
Journal:  FASEB J       Date:  2008-06-20       Impact factor: 5.191

Review 7.  Roles and regulation of secretory and lysosomal acid sphingomyelinase.

Authors:  Russell W Jenkins; Daniel Canals; Yusuf A Hannun
Journal:  Cell Signal       Date:  2009-06       Impact factor: 4.315

8.  Acid sphingomyelinase activity is regulated by membrane lipids and facilitates cholesterol transfer by NPC2.

Authors:  Vincent O Oninla; Bernadette Breiden; Jonathan O Babalola; Konrad Sandhoff
Journal:  J Lipid Res       Date:  2014-10-22       Impact factor: 5.922

9.  Crystal structure of mammalian acid sphingomyelinase.

Authors:  Alexei Gorelik; Katalin Illes; Leonhard X Heinz; Giulio Superti-Furga; Bhushan Nagar
Journal:  Nat Commun       Date:  2016-07-20       Impact factor: 14.919

10.  Identification and characterization of the Onchocerca volvulus Excretory Secretory Product Ov28CRP, a putative GM2 activator protein.

Authors:  Ferdinand Ngale Njume; Stephen Mbigha Ghogomu; Robert Adamu Shey; Lea Olive Tchouate Gainkam; Philippe Poelvoorde; Perrine Humblet; Joseph Kamgno; Annie Robert; Leon Mutesa; Christophe Lelubre; Evelina Edelweiss; Arnaud Poterszman; Susi Anheuser; Luc Vanhamme; Jacob Souopgui
Journal:  PLoS Negl Trop Dis       Date:  2019-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.